Compare ARK Space & Defense Innovation ETF (ARKX) vs Ascendis Pharma A/S (ASND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Space & Defense Innovation ETF vs Ascendis Pharma A/S — how do they compare? ARK Space & Defense Innovation ETF trades at $34.39, while Ascendis Pharma A/S trades at $254.5 (market cap $16.67B). Which is the better fit depends on your goals.
| ARKX | ASND | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $37.74 | $277.18 |
52-Week Low | $25.46 | $189.74 |
Market Cap | — | $16.67B |
Enterprise Value | — | $17.04B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Space & Defense Innovation ETF
ARKX is an actively managed ETF that invests in companies leading space exploration and defense innovation. It focuses on orbital and sub-orbital aerospace, reusable rockets, and enabling technologies like AI, robotics, and satellite systems.
Read more on ARKX →About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →
